Pay in 4 interest-free payments of $5.70 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Coverage at NY Times, front page today and my input to that piece Instead of focusing on banning things a small subset of people are using and seeing benefit in, can we focus on modernizing the clinical trial system to promote efficient drug development
You're already on GLP-1 to feel better
The high proportion of individuals who were overweight or obese may also be due, in part, to the funneling of overweight and obese individuals towards DOR and away from INSTI- and TAF-containing regimens, for which associations with weight gain have been widely discussed [2,3,4]
10.1093/intimm/dxx031 Int Immunol
US$ 24.33
US$ 26.66
US$ 20.22
US$ 24.70
US$ 27.36
US$ 25.93
